DOP2008000021A - Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat, procedimiento de preparacion de la composicion y su uso para el tratamiento de la obesidad - Google Patents
Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat, procedimiento de preparacion de la composicion y su uso para el tratamiento de la obesidadInfo
- Publication number
- DOP2008000021A DOP2008000021A DO2008000021A DO2008000021A DOP2008000021A DO P2008000021 A DOP2008000021 A DO P2008000021A DO 2008000021 A DO2008000021 A DO 2008000021A DO 2008000021 A DO2008000021 A DO 2008000021A DO P2008000021 A DOP2008000021 A DO P2008000021A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- agent
- orlistat
- pharmaceutical composition
- composition
- obesity
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title abstract 3
- 229960001243 orlistat Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 239000006096 absorbing agent Substances 0.000 abstract 2
- 238000010790 dilution Methods 0.000 abstract 2
- 239000012895 dilution Substances 0.000 abstract 2
- 239000007884 disintegrant Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 abstract 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
- 229940079832 sodium starch glycolate Drugs 0.000 abstract 1
- 239000008109 sodium starch glycolate Substances 0.000 abstract 1
- 229920003109 sodium starch glycolate Polymers 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2007002287A CL53426B (enExample) | 2007-08-06 | 2007-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2008000021A true DOP2008000021A (es) | 2009-11-30 |
Family
ID=51359501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2008000021A DOP2008000021A (es) | 2007-08-06 | 2008-04-10 | Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat, procedimiento de preparacion de la composicion y su uso para el tratamiento de la obesidad |
Country Status (7)
| Country | Link |
|---|---|
| CL (1) | CL53426B (enExample) |
| CR (1) | CR10132A (enExample) |
| DO (1) | DOP2008000021A (enExample) |
| MX (1) | MX2008010082A (enExample) |
| PA (1) | PA8786701A1 (enExample) |
| PE (1) | PE20091224A1 (enExample) |
| SV (1) | SV2009002991A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL216542B1 (pl) * | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku |
-
2007
- 2007-08-06 CL CL2007002287A patent/CL53426B/es active
- 2007-10-25 PE PE2007001452A patent/PE20091224A1/es active IP Right Grant
-
2008
- 2008-04-10 DO DO2008000021A patent/DOP2008000021A/es unknown
- 2008-07-01 PA PA20088786701A patent/PA8786701A1/es unknown
- 2008-07-07 CR CR10132A patent/CR10132A/es not_active Application Discontinuation
- 2008-07-31 SV SV2008002991A patent/SV2009002991A/es unknown
- 2008-08-06 MX MX2008010082A patent/MX2008010082A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008010082A (es) | 2009-04-17 |
| CL2007002287A1 (enExample) | 2007-12-14 |
| SV2009002991A (es) | 2009-04-16 |
| CR10132A (es) | 2008-10-28 |
| PA8786701A1 (es) | 2009-04-23 |
| PE20091224A1 (es) | 2009-08-26 |
| CL53426B (enExample) | 2016-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0713777B8 (pt) | processo para preparação de formulações de pó seco de um sal de glicopirrônio para inalação | |
| EP3928800A3 (en) | Dry powder composition comprising long-chain rna | |
| SG190448A1 (en) | Rapidly dispersing granules, orally disintegrating tablets and methods | |
| ES2923214T3 (es) | Composición farmacéutica que comprende mesilato de lenvatinib | |
| BRPI0709847B8 (pt) | composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio | |
| CO6720961A2 (es) | Imidazopiridazinas sustituidas | |
| IS8669A (is) | Rasagilínlyfjablöndur sem einsleitni innihaldsefna hefur verið endurbætt í | |
| NZ599594A (en) | Fast dissolving solid dosage form | |
| HRP20200055T1 (hr) | Eutektičke formulacije ciklobenzaprin-klorovodika i manitola | |
| CO6761350A2 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis | |
| FI4066821T3 (fi) | Neratinibimaleaatin tablettiformulaatioita | |
| HRP20140876T1 (hr) | Rifaksimin u prahu, postupak za dobivanje istog i pripravci sa kontroliranim oslobađanjem koji sadrže navedeni rifaksimin te koji su korisni za dobivanje dugotrajnog djelovanja | |
| AR111570A1 (es) | Composición farmacéutica que comprende selexipag | |
| UA106877C2 (uk) | Фармацевтична композиція ентакапону або його солей пролонгованого вивільнення | |
| WO2008127358A3 (en) | Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof | |
| NZ596503A (en) | Adjuvant compositions comprising a non-ionic isotonicity agent | |
| UY29410A1 (es) | Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones. | |
| CU20200008A7 (es) | Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas, métodos para preparar dichos compuestos y composiciones farmacéuticas que los contienen | |
| GEAP202014783A (en) | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | |
| BR112021019104A2 (pt) | Micropartículas secas | |
| BR112015029773A2 (pt) | pós revestidos com aroma | |
| WO2016184577A3 (en) | Dry powder composition comprising long-chain rna | |
| PE20151024A1 (es) | Composicion farmaceutica novedosa | |
| HRP20191217T1 (hr) | Čvrsti farmaceutski sastav citizina i postupak pripreme istog | |
| MY209656A (en) | Compositions and methods of enhancing 5-hydroxytryptophan bioavailability |